METHOD FOR TREATING NERVOUS SYSTEM DISORDERS AND CONDITIONS

摘要

The present invention is directed to selective dopamine reuptake inhibitors, including (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, (-)-1-(4­methylphenyl)-3-azabicyclo[3.1.0]hexane, mazindol, methylphenidate, and 1-[2­[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) piperazine, and methods of their use for treating certain nervous system disorders and conditions, including,